Why Choose CatSci?
Crystallisation and Solid State Expertise
Dr Robert Dennehy, our Director of Material Sciences leads our material sciences team. Robert has 20+ years of Large Pharma experience in the field of crystallisation and solid state of pharmaceuticals.
His industry experience and integrated approach to particle science and preformulation development allow him to solve customers’ problems effectively with a high degree of scientific rigour.
Dr Gary Parsons, our Director of Pharmaceutical Development, leads our preformulation team. Gary has 20+ years of Large Pharma experience in formulation development of small molecules, proteins, and RNA-based therapeutics.
Gary is committed to integrating API material science into dosage form design to give customers flexibility and optionality when it comes to pharmaceutical product design.
Through our end-in-mind approach we link particle science to formulation and process understanding, maximising the chance of your small molecule success
Our integrated chemical development, material science, preformulation and analytical development teams offer a holistic approach to medicines development, breaking down the barriers between drug substance and drug product.
SmartPath is our innovative digital tool that risk assesses your API, project, and formulation data and offers actionable mitigation strategies from our crystallisation and solid state expert, Dr Robert Dennehy.
When it comes to your API project you need to know what the risks are, the threat they pose, and how to alleviate them. SmartPath eliminates the guesswork and presents you with answers.
Discover our Crystallisation, Solid State and Preformulation Equipment, including our Blaze 900 probe
Take a 360° Virtual Tour of our State-of-the-Art Crystallisation, Solid State and Preformulation Laboratory
Check out our Case Study on Understanding the Polymorph Landscape of an API
Partnering from pre-clinical to product launch
Crystallisation, Solid State & Preformulation
Early solid state characterisation
Version (salt) screening & selection
Particle & formulation risk assessment for FTIH
Computational assessment using CCDC informatics tools
Preformulation including formulation definition for pre-clinical studies
Crystallisation development & optimisation
QbD process understanding & robustness
Control strategy for solid state & bulk properties
Comprehensive physical properties measurement capability
In-situ particle measurement & imaging
Filtration & washing optimisation